The University of Southampton
University of Southampton Institutional Repository

Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status

Trebble, T.M., Wootton, S.A., Stroud, M.A., Mullee, M.A., Calder, P.C., Fine, D.R., Moniz, C. and Arden, N.K. (2004) Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status Alimentary Pharmacology & Therapeutics, 19, (10), pp. 1063-1071. (doi:10.1111/j.1365-2036.2004.01943.x).

Record type: Article

Abstract

Background: Crohn's disease is associated with reduced bone density. The power of simple markers of systemic inflammation to identify higher rates of bone loss, in Crohn's disease, is uncertain. This relationship and the role of circulating (peripheral blood) mononuclear cells were investigated in a case-control study.
Methods: Urinary deoxypyridinoline/creatinine and serum osteocalcin concentrations were compared in male and premenopausal females with "active" Crohn's disease (C-reactive protein > or = 10 and/or erythrocyte sedimentation rate > or = 20) (n = 22) and controls with "quiescent" Crohn's disease (C-reactive protein < 10 and erythrocyte sedimentation rate < 20) (n = 21). No patients were receiving corticosteroid therapy. Production of tumour necrosis factor-alpha, interferon-gamma and prostaglandin E(2) by peripheral blood mononuclear cells were measured.
Results Active Crohn's disease was associated with a higher deoxypyridinoline/creatinine (P = 0.02) and deoxypyridinoline/creatinine:osteocalcin ratio (P =0.01) compared with quiescent Crohn's disease, but similar osteocalcin (P = 0.24). These were not explained by vitamin D status, dietary intake or nutritional status. However, production of interferon-gamma by concanavalin A-stimulated peripheral blood mononuclear cells was lower in active Crohn's disease (P = 0.02) and correlated negatively with the deoxypyridinoline/creatinine:osteocalcin ratio (r = -0.40, P = 0.004).
Conclusion: In Crohn's disease, raised C-reactive protein and erythrocyte sedimentation rate may indicate higher rates of bone loss and, if persistent, the need to assess bone mass even where disease symptoms are mild. This may be partly explained by altered production of interferon-gamma by peripheral blood mononuclear cells

Full text not available from this repository.

More information

Published date: 2004
Keywords: necrosis, role, crohn's disease, physiopathology, blood sedimentation, protein, bone mass, physiology, laboratories, bone density, nutrition, serum, inflammation, non-u.s.gov't, metabolism, patients, bone resorption, crohn disease, bone, methods, human, case-control studies, bone remodeling, research support, male, humans, adult, disease, osteocalcin, blood, cytokines, prostaglandins, c-reactive protein, female, therapy, vitamin d, analysis, nutritional status

Identifiers

Local EPrints ID: 24531
URI: http://eprints.soton.ac.uk/id/eprint/24531
ISSN: 0269-2813
PURE UUID: ddb3d106-ed41-4401-8703-e7bab2e8763c

Catalogue record

Date deposited: 31 Mar 2006
Last modified: 12 Jul 2017 16:31

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×